| [1] |
Bray F, Ferlay J, Soerjomataram I, et al.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Cancer J ClinCancer J Clin, 2018, 68(6): 394-424.
doi: 10.3322/caac.21492 |
| [2] |
Kumar S, Metz DC, Ellenberg S, et al.
Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study[J]. GastroenterologyGastroenterology, 2020, 158(3): 527-536.
doi: 10.1053/j.gastro.2019.10.019 |
| [3] |
Koga H, Sasaki M, Kuwabara Y, et al.
An analysis of the physiological FDG uptake pattern in the stomach[J]. Ann Nucl MedAnn Nucl Med, 2003, 17(8): 733-738.
doi: 10.1007/BF02984984 |
| [4] |
Farghaly H, Alshareef M, Alqarni A, et al. Dual time point [18F]Flurodeoxyglucose (FDG) positron emission tomography (PET) /computed tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions[J/OL]. Eur J Radiol Open, 2020, 7: 100268[2020-10-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490534. DOI: 10.1016/j.ejro.2020.100268. |
| [5] |
Takahashi H, Ukawa K, Ohkawa N, et al.
Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography[J]. Ann Nucl MedAnn Nucl Med, 2009, 23(4): 391-397.
doi: 10.1007/s12149-009-0255-3 |
| [6] |
王欣, 于丽娟, 陆佩欧, 等.
临床隐匿性胃癌的FDG PET/CT征象[J]. 世界华人消化杂志世界华人消化杂志, 2012, 20(36): 3695-3700.
doi: 10.11569/wcjd.v20.i36.3695 Wang X, Yu LJ, Lu PO, et al. FDG PET/CT diagnosis of clinically occult gastric cancer[J]. World Chin J DigestolWorld Chin J Digestol, 2012, 20(36): 3695-3700. doi: 10.11569/wcjd.v20.i36.3695 |
| [7] |
Kamimura K, Nagamachi S, Wakamatsu H, et al.
Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET[J]. Nucl Med CommunNucl Med Commun, 2009, 30(6): 431-439.
doi: 10.1097/MNM.0b013e3283299a2f |
| [8] |
Zhu ZH, Li F, Mao YL, et al.
Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning[J]. J Nucl Med TechnolJ Nucl Med Technol, 2008, 36(1): 25-29.
doi: 10.2967/jnmt.107.044081 |
| [9] |
Yoon JK, Byun C, Jo KS, et al.
Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET[J]. Medicine (Baltimore)Medicine (Baltimore), 2019, 98(31): e16690-.
doi: 10.1097/MD.0000000000016690 |
| [10] |
Chung HW, Kim JH, Sung IK, et al.
FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer[J]. J Cancer Res Clin OncolJ Cancer Res Clin Oncol, 2019, 145(3): 759-764.
doi: 10.1007/s00432-018-02832-9 |
| [11] |
Shimada H, Okazumi S, Koyama M, et al.
Japanese gastric cancer association task force for research promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature[J]. Gastric CancerGastric Cancer, 2011, 14(1): 13-21.
doi: 10.1007/s10120-011-0017-5 |
| [12] |
Chon HJ, Kim C, Cho A, et al.
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer[J]. Gastric CancerGastric Cancer, 2019, 22(1): 113-122.
doi: 10.1007/s10120-018-0847-5 |
| [13] |
Findlay JM, Antonowicz S, Segaran A, et al.
Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery[J]. Eur RadiolEur Radiol, 2019, 29(5): 2490-2498.
doi: 10.1007/s00330-018-5904-2 |
| [14] |
Coupe NA, Karikios D, Chong S, et al.
Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer[J]. Ann Nucl MedAnn Nucl Med, 2014, 28(2): 128-135.
doi: 10.1007/s12149-013-0791-8 |
| [15] |
Kawamura T, Kusakabe T, Sugino T, et al.
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival[J]. CancerCancer, 2001, 92(3): 634-641.
doi: 10.1002/1097-0142(20010801)92:3<634::aid-cncr1364>3.0.co;2-x |
| [16] |
Alakus H, Batur M, Schmidt M, et al.
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression[J]. Nucl Med CommunNucl Med Commun, 2010, 31(6): 532-538.
doi: 10.1097/MNM.0b013e32833823ac |
| [17] |
Lim JY, Yoon SO, Seol SY, et al.
Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer[J]. World J GastroenterolWorld J Gastroenterol, 2012, 18(30): 4037-4043.
doi: 10.3748/wjg.v18.i30.4037 |
| [18] |
Lehmann K, Eshmuminov D, Bauerfeind P, et al.
18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma[J]. Eur J Surg OncolEur J Surg Oncol, 2017, 43(1): 196-202.
doi: 10.1016/j.ejso.2016.08.020 |
| [19] |
Kim SK, Kang KW, Lee JS, et al.
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2006, 33(2): 148-155.
doi: 10.1007/s00259-005-1887-8 |
| [20] |
Kim EY, Lee WJ, Choi D, et al.
The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT[J]. Eur J RadiolEur J Radiol, 2011, 79(2): 183-188.
doi: 10.1016/j.ejrad.2010.02.005 |
| [21] |
Tang L, Wang XL, Baba H, et al.
Gastric cancer and image-derived quantitative parameters: part 2— a critical review of DCE-MRI and 18F-FDG PET/CT findings[J]. Eur RadiolEur Radiol, 2020, 30(1): 247-260.
doi: 10.1007/s00330-019-06370-x |
| [22] |
Song BI, Kim HW, Won KS, et al.
Preoperative standardized uptake value of metastatic lymph nodes measured by 18F-FDG PET/CT improves the prediction of prognosis in gastric cancer[J]. Medicine (Baltimore)Medicine (Baltimore), 2015, 94(26): e1037-.
doi: 10.1097/MD.0000000000001037 |
| [23] |
Wang X, Wei YZ, Xue YW, et al. Predictive role of the number of 18F-FDG-positive lymph nodes detected by PET/CT for pre-treatment evaluation of locally advanced gastric cancer[J/OL]. PLoS One, 2016, 11(12): e0166836[2019-08-10]. https://pubmed.ncbi.nlm.nih.gov/27936109. DOI: 10.1371/journal.pone.0166836. |
| [24] |
Kwon HW, An L, Kwon HR, et al.
Preoperative nodal 18F-FDG avidity rather than primary tumor avidity determines the prognosis of patients with advanced gastric cancer[J]. J Gastric CancerJ Gastric Cancer, 2018, 18(3): 218-229.
doi: 10.5230/jgc.2018.18.e23 |
| [25] |
Chen J, Cheong JH, Yun MJ, et al.
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography[J]. CancerCancer, 2005, 103(11): 2383-2390.
doi: 10.1002/cncr.21074 |
| [26] |
Kawanaka Y, Kitajima K, Fukushima K, et al.
Added value of pretreatment 18F-FDG PET/CT for staging of advanced gastric cancer: comparison with contrast-enhanced MDCT[J]. Eur J RadiolEur J Radiol, 2016, 85(5): 989-995.
doi: 10.1016/j.ejrad.2016.03.003 |
| [27] |
Serrano OK, Love C, Goldman I, et al.
The value of FDG-PET in the staging of gastric adenocarcinoma: a single institution retrospective review[J]. J Surg OncolJ Surg Oncol, 2016, 113(6): 640-646.
doi: 10.1002/jso.24190 |
| [28] |
Bosch KD, Chicklore S, Cook GJ, et al.
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2020, 47(4): 759-767.
doi: 10.1007/s00259-019-04429-x |
| [29] |
Smyth E, Schöder H, Strong VE, et al.
A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer[J]. CancerCancer, 2012, 118(22): 5481-5488.
doi: 10.1002/cncr.27550 |